Olin's Q2 Results: Resilience Tested by Shutdowns as Huntsman Merger Nears

CLAYTON, MO – July 30, 2026 – Olin Corporation (NYSE: OLN) today presented a complex picture to investors, reporting second-quarter results that showcase both operational resilience and significant vulnerability. While the chemical and ammunition manufacturer delivered a year-over-year increase in adjusted EBITDA, a costly plant shutdown pushed the company to a wider net loss, all while it navigates the intricate and expensive process of a transformative merger with Huntsman Corporation.

The company announced a Q2 2026 net loss of ($13.3) million, or ($0.12) per diluted share, a notable decline from the ($1.3) million net loss reported in the same quarter last year. This bottom-line figure, which missed analyst expectations, stands in stark contrast to the sequential and year-over-year improvement in adjusted EBITDA, which rose to $191.3 million from $176.1 million in Q2 2025. This divergence highlights a company grappling with major operational headwinds that are currently overshadowing underlying performance improvements and strategic cost-cutting measures.

An Operational Tug-of-War

A deep dive into Olin's segment performance reveals a story of diverging fortunes. The primary drag on profitability was a significant unplanned shutdown at the vinyl chloride monomer (VCM) plant in Freeport, Texas. This single event proved costly, slashing second-quarter adjusted EBITDA by an estimated $40 million. The pain is set to continue, with management forecasting an additional $20 million impact in the third quarter as the facility only gradually ramps back up to full capacity.

This isn't the first time the Freeport facility has caused headaches, with a history of prior shutdowns impacting production and supply chains. The disruption directly hit the Chlor Alkali Products and Vinyls segment, which saw sales fall to $819.5 million from $979.5 million a year ago. Segment earnings also dropped, heavily impacted by the $40.1 million in higher costs and lost sales stemming from the outage. Despite this, CEO Ken Lane credited the team for delivering "sequential improvement in adjusted EBITDA in a highly volatile environment," pointing to improved caustic soda pricing and cost-saving actions.

However, away from the issues in Texas, other parts of Olin's portfolio demonstrated considerable strength. The Epoxy segment was a standout performer, executing a dramatic turnaround from a segment loss of ($23.7) million in Q2 2025 to a profit of $16.0 million. This $39.7 million positive swing was achieved through higher volumes and improved product margins, a commendable feat given what the company described as "persistent weak demand conditions in Europe." A new supply agreement at its Stade, Germany facility, expected to deliver an annual EBITDA benefit of around $40 million, appears to be bolstering the segment's European economics.

Meanwhile, the Winchester ammunition division continued its role as a reliable growth engine. The segment posted sales of $500.3 million, up from $447.6 million in the prior year, with earnings climbing to $28.1 million. The growth was fueled by robust commercial ammunition demand and pricing actions taken to offset rising commodity metal costs, alongside higher revenue from military projects. This steady performance provides crucial diversification and a buffer against the inherent volatility of Olin's core chemical businesses.

The Multi-Billion Dollar Question: OlinHuntsman

Looming over these quarterly results is the proposed all-stock merger of equals with Huntsman Corporation, a deal that promises to create a chemical powerhouse, OlinHuntsman Corporation. The strategic move is already impacting the bottom line, with Olin recording $10.6 million in acquisition-related costs for advisory, legal, and other professional fees during the quarter.

The merger process is advancing. The U.S. Securities and Exchange Commission (SEC) declared Olin's Form S-4 registration statement effective earlier this month, and special shareholder meetings for both companies are now scheduled for August 25, 2026. If approved and all other conditions are met, the deal is expected to close in the first half of 2027.

The strategic prize, according to the companies, is the creation of a more vertically integrated entity, combining Olin's upstream feedstock and manufacturing muscle with Huntsman's downstream product and formulation expertise. Management is targeting over $400 million in total synergies, including more than $300 million in annual cost savings and integration benefits within three years of closing. While the long-term vision is compelling, some analysts caution that the combined entity will still face near-term macroeconomic headwinds and will begin its life with significant balance sheet leverage.

A High-Wire Act on the Balance Sheet

The costs of the merger and the operational stumbles are putting Olin's financial health under the microscope. The company ended the quarter with approximately $2.85 billion in net debt. Its net debt to trailing twelve months adjusted EBITDA ratio now stands at a lofty 5.0 times, a level that suggests limited financial flexibility and little room for error in a notoriously cyclical industry.

To its credit, management can point to a still-strong liquidity position of approximately $1.2 billion, including full access to its revolving credit facility, which provides a significant cushion. However, cash continues to be deployed for non-operational purposes. The company paid out roughly $93 million in the first half of the year to resolve legacy litigation matters with Shintech and expects to pay another $100 million in the second half.

In this environment, Olin's focus on operational efficiency through its "Beyond250" structural cost actions becomes even more critical. This program, which targets over $250 million in savings by 2028, was cited by CEO Ken Lane as a key driver of favorable operating performance in the Chlor Alkali segment. For investors, the success of these internal initiatives is a key variable in the company's ability to manage its debt and fund its strategic ambitions.

Charting a Course Through Choppy Waters

Looking ahead, Olin's own forecast for the third quarter suggests the challenging conditions will persist. The company projects adjusted EBITDA to be in the range of $160 million to $200 million. This guidance reflects a delicate balance of competing forces: the lingering impact of the Freeport VCM facility's reduced rates and weaker ethylene dichloride pricing are expected to offset stronger caustic soda volumes and sequential earnings growth from the Winchester segment.

The broader market for Olin's key products remains soft. Global caustic soda prices have been under downward pressure due to abundant supply, particularly from Asia, and moderate downstream demand. This external environment adds another layer of complexity to Olin's internal efforts to stabilize and grow profitability. For investors, the quarter serves as a stark reminder of the complexities inherent in the chemical sector, where a single plant outage can obscure underlying progress and a massive merger promises a fundamentally different future.